Stock Market Today: Stocks Fall After Fed Speeches
The major indexes finished lower Wednesday amid hawkish commentary from several Federal Reserve officials.


Selling on Wall Street resumed Wednesday, with the major benchmarks spending the entirety of the session in negative territory.
In focus today were speeches from several Federal Reserve officials – especially following Fed Chair Jerome Powell's message yesterday that indicated the central bank's fight against inflation is far from over. The latest batch of earnings reports also moved stocks. These included well-received results for ride-sharing firm Uber Technologies (UBER) and pharmacy chain CVS Health (CVS).
The most talked about Fed comments today came from New York Fed President John Williams. In an interview with the Wall Street Journal, Williams said that the Fed still has its work cut out for it, and that the central bank will likely have to maintain a "sufficiently restrictive stance on policy" for a few years in order to bring inflation down to its 2% target.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"U.S. stocks declined after [New York Fed President] Williams did the pushback that everyone was expecting Fed Chair Powell to do," says Edward Moya, senior market strategist at currency data provider OANDA. "Williams quickly sank risk appetite after he reminded Wall Street that if financial conditions loosen, higher rates may be needed."
On the earnings front, Uber stock jumped 5.5% after the company said fourth-quarter revenue surged 49% year-over-year to $8.6 billion, while adjusted earnings rose to $665 million from $86 million in the year-ago period. Gross bookings were also up, jumping 19% to $30.7 billion.
Meanwhile, CVS reported fourth-quarter earnings of $1.99 per share on $83.8 billion in revenue. Both figures were higher on a year-over-year basis and came in above consensus estimates. The real news for CVS, though, was that it agreed to buy Oak Street Health (OSH, +4.6%) – an operator of primary care centers across the U.S. – for $10.6 billion, including debt. CVS stock rose 3.5% on the day.
As for the major indexes, the Dow Jones Industrial Average fell 0.6% to 33,949, the S&P 500 shed 1.1% to 4,117, and the Nasdaq Composite declined 1.7% to 11,910.
The Best Tech Stocks to Buy
Today's underperformance by the Nasdaq marks a change of pace to what we've seen for most of 2023. Year-to-date, the tech-heavy index is up 13.8%, compared to a 7.3% gain for the S&P 500 and a 2.4% return for the Dow. This follows an absolutely terrible 2022 for the tech sector, which "fell victim to the Federal Reserve's (Fed) campaign to quell inflation by aggressively raising rates," says Quincy Krosby, chief global strategist for LPL Financial.
And even "as the Fed continues to make clear that its job isn't finished, tech stocks nonetheless continue to lead market rallies," Krosby adds. Part of this, she says, is the robust cost-cutting measures technology companies have taken in recent months, including layoffs. But investors are also looking for innovation from these firms, the kind that propels them into our everyday lives. The strategist points to artificial intelligence (AI) as one potential catalyst "that helps drive the sector into its next phase," which makes these top AI stocks worth a closer look. For investors looking for even more opportunities, here are the best tech stocks to buy now. Many names featured on this list are focused on secular megatrends that could continue to power growth for years to come, including AI, cloud computing and cybersecurity.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
The Most Tax-Friendly State for Retirement in 2025: Here It Is
Retirement Tax How do you retire ‘tax-free’? This state doesn’t tax retirement income, has a low median property tax bill, and even offers savings on gas. Are you ready for a move?
-
Plan for Higher Health Care Costs in 2026: Projected Medicare Part B and Part D Premiums
In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's what you can do.
-
Dow Dives 542 Points on Soft Jobs Data: Stock Market Today
The last day of a busy week ends with the first greater-than-1% move in either direction in more than a month.
-
July Jobs Report Renews Rate-Cut Hopes: What the Experts Are Saying
The July jobs report shows weakening in the labor market and lifts expectations for a September rate cut.
-
Should You Buy These ETFs Before the Fed Cuts Rates?
The Fed is likely to lower interest rates this fall, and tactical investors may want to look closer at these ETFs before rate cuts resume.
-
Stocks Can't Hold Meta, Microsoft Gains: Stock Market Today
The main indexes all opened higher Thursday on impressive Big Tech earnings, but momentum faded into the close.
-
How to Invest for a Fall Interest Rate Cut by the Fed
A lot can happen between now and then, but the probability the Fed cuts interest rates in September is back above 80%.
-
Stocks Are Up and Down on Fed Day: Stock Market Today
In another sign of changing times, JPMorgan has partnered with Coinbase to enable cryptocurrency purchases with credit cards.
-
UnitedHealth Stock Drags on Dow: Stock Market Today
Corporate earnings have dominated Wall Street's attention this week, but that changes on Wednesday.
-
Stocks Close Mixed to Start Fed Week: Stock Market Today
News of an EU-U.S. trade deal was met with muted reaction from market participants who are looking ahead to a jam-packed week.